Prostatic Hyperplasia: Clinical Trials

15 trials for Prostatic Hyperplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 unknown. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Unknown 15

Follow Prostatic Hyperplasia: new trials by email Literature Review of Prostatic Hyperplasia trials Research Report on Prostatic Hyperplasia

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.
Mirabegron, Tamsulosin - Overactive Bladder, Benign Prostatic Hyperplasia
Phase 4UnknownSt. Joseph's Healthcare Hamilton2002021-12-012021-03-19
Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB
Tadalafil 5mg, Tamsulosin Hcl 0.4 mg, solifenacin 10 mg - Benign Prostatic Hyperplasia, Overactive Bladder
Phase 4UnknownMansoura University602021-11-082022-08-10
Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasia
Dexamethasone, Saline - Prostatic Hyperplasia
Phase 4UnknownCopenhagen University Hospital, Rigshospitalet602021-03-012022-03-22
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy
Diclofenac Sodium, Cystoscopy, Lubricant Gel - Bladder Cancer, Benign Prostate Hyperplasia
Phase 4UnknownTaha Uçar1442018-12-112019-02-05
Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLight Laser Photoselective Vaporization of the Prostate
Non-ejaculatory sparring PVP, Ejaculatory sparring PVP - Prostatic Hyperplasia
Phase 4UnknownMansoura University402016-03-012016-04-25
Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency
HoLEP, Greenlight laser PVP - Benign Prostatic Hyperplasia
Phase 4UnknownMansoura University602014-10-012016-03-29
Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients
Green light PVP, Prostatic artery embolization - Benign Prostate Hyperplasia, Urinary Retention
Phase 4UnknownRoyal Victoria Hospital, Canada732013-12-012014-11-04
Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications
i-gel, C-LMA - Bladder Tumour, Prostate Hyperplasia
Phase 4UnknownDiskapi Yildirim Beyazit Education and Research Hospital1202013-07-012013-06-13
Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.
Heavy Bupivacaine, Isobaric Bupivacaine - Benign Prostate Hyperplasia
Phase 4UnknownDiskapi Yildirim Beyazit Education and Research Hospital522013-05-012013-05-23
Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
Tamsulosin, Finasteride, Placebo - Benign Prostate Hyperplasia
Phase 4UnknownSeoul National University Hospital5452012-02-012014-05-14
Bioequivalence Study of Tansulosine 0,4 mg Capsule in Health Subjects -Fed State
Tansulosine - Hyperplasia Prostatic
Phase 4UnknownBiocinese322011-04-012011-05-03
Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions
Saw palmetto berry extract - Sexual Dysfunctions in Men With Benign Prostatic Hyperplasia
Phase 4UnknownA. Vogel AG502009-11-012009-11-26
A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart
Dutasteride - Benign Prostatic Hyperplasia
Phase 4UnknownUrologic Consultants of Southeastern PA502008-05-012008-06-05
Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)
Prolieve - Benign Prostate Hyperplasia
Phase 4UnknownMedifocus, Inc.2502006-02-012015-09-24
Kinetics of the Finasteride Prostate Induced Apoptosis
finasteride - Benign Prostatic Hyperplasia
Phase 4UnknownHospices Civils de Lyon902004-12-012007-04-27

Narrower conditions

Urinary Bladder Neoplasms (2)  ·  Urinary Bladder, Overactive (2)  ·  Hematuria (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Pain (1)  ·  Urinary Retention (1)

Broader conditions

Genital Diseases (15)  ·  Genital Diseases, Male (15)  ·  Male Urogenital Diseases (15)  ·  Prostatic Diseases (15)  ·  Urogenital Diseases (15)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Urologic Diseases (5)  ·  Urinary Bladder Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Urological Manifestations (3)  ·  Lower Urinary Tract Symptoms (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)

Interventions

Tamsulosin (3)  ·  Finasteride (2)  ·  Cystoscopy (1)  ·  Dexamethasone (1)  ·  Diclofenac (1)  ·  Dutasteride (1)  ·  Photoelectron Spectroscopy (1)  ·  Prostasan (1)  ·  Sodium Chloride (1)  ·  Solifenacin Succinate (1)  ·  Tadalafil (1)  ·  mirabegron (1)  ·  saw palmetto extract (1)

Sponsors

Mansoura University (3)  ·  Diskapi Yildirim Beyazit Education and Research Hospital (2)  ·  A. Vogel AG (1)  ·  Biocinese (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Hospices Civils de Lyon (1)  ·  Medifocus, Inc. (1)  ·  Royal Victoria Hospital, Canada (1)  ·  Seoul National University Hospital (1)  ·  St. Joseph's Healthcare Hamilton (1)  ·  Taha Uçar (1)  ·  Urologic Consultants of Southeastern PA (1)

Countries

Egypt (3)  ·  Turkey (Türkiye) (3)  ·  Canada (2)  ·  United States (2)  ·  Brazil (1)  ·  Denmark (1)  ·  France (1)  ·  South Korea (1)  ·  Switzerland (1)

Top investigators

Ahmed Elhefnawy (1)  ·  Ahmed Elshal (1)  ·  Anil Kapoor, MD, FRCSC (1)  ·  Eugen Riedi, MD (1)  ·  Lars B Lonn, MD, PhD (1)  ·  Mohammed Hegazy (1)  ·  Mostafa Elhilali, MD,PhD,FRCSC (1)  ·  Perry Weiner, MD (1)  ·  Reyhan Polat, MD (1)

Results publications

PMID 34314241, PMID 34725072